Last reviewed · How we verify

NCT03644927

Exercise Maintenance in Chronic Pain and PTSD

Terminated NA Results posted Last updated 25 January 2023
What this trial tests

NA trial testing Progressive exercise training in Chronic Low Back Pain in 11 participants. Terminated before completion.

Timeline
22 January 2019
Primary endpoint
6 January 2022
6 January 2022

Quick facts

Lead sponsorBoston University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment11
Start date22 January 2019
Primary completion6 January 2022
Estimated completion6 January 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston University

Who can join

Adults 18 to 65, any sex, with Chronic Low Back Pain or Posttraumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Adverse events — posted to ClinicalTrials.gov

Time frame: Adverse events were collected for the 6 weeks that one participant received the study intervention prior to study termination. In addition prior to randomization two participants had an adverse event during the rigorous and conservative screening process and they were not allowed to proceed to the intervention. One participant felt nauseous and had a headache and the other had abnormal EKG findings and a positive history for cardiac issues.. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Progressive Exercise Program
Serious: 0/11 (0%)
Deaths: 0/11
Other adverse events (3 terms — click to expand)

ReactionSystemProgressive Exercise Program
NauseaGastrointestinal disorders
HeadacheGeneral disorders
Cardiac abnormalitiesCardiac disorders

Data from ClinicalTrials.gov NCT03644927 adverse events section.

Sponsor's own description

The primary purpose of the R21 is using an experimental medicine research approach to study whether a chronic, progressive-based exercise program will help Veterans suffering from chronic low back pain (cLBP) and PTSD achieve exercise maintenance, and shared symptom reduction, through neuropeptide Y mediated improvements in putative factors (self-regulation and reward sensitivity) known to improve exercise related self-efficacy and motivation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Moderated mediation for exercise maintenance in pain and posttraumatic stress disorder: A randomized trial.
    Scioli ER, Smith BN, Whitworth JW, Spiro A, et al · · 2020 · cited 3× · PMID 32833484 · DOI 10.1037/hea0000876

Verify or expand the search:

Other recruiting trials for Chronic Low Back Pain

Currently open trials in the same condition.

Other Boston University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03644927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing